Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes
AssigneesNational University Corporation Tokyo University of Marine Science and Technology, Kewpie Corporation
InventorsHajime Takahashi, Miki Sato, Takashi Miyashita, Ryo Sasahara
Life of this patent
Estimating the term…
Abstract
Provided is a norovirus deactivator, including a lysozyme component that includes at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.
Claims20
A norovirus deactivator, comprising a lysozyme component that comprises at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.
A method of deactivating norovirus, the method comprising deactivating norovirus using a lysozyme component that comprises at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.
A method of producing a norovirus deactivator, the method comprising incorporating a lysozyme component that comprises at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.
A prophylactic agent or therapeutic agent for norovirus infection, comprising a lysozyme component that comprises at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.
An external preparation for skin for norovirus deactivation purposes, comprising a lysozyme component that comprises at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.
A lysozyme component for norovirus deactivation use, comprising at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.
A prophylactic agent or therapeutic agent for acute viral gastroenteritis, comprising a lysozyme component that comprises at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.
A method for preventing or treating acute viral gastroenteritis, comprising taking a lysozyme component that comprises at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof
Dependencies are inferred from the claim text.